Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aczone plus Differin vs Duac plus Differin in Severe Facial Acne
NCT01231334Phase 4Completed
- Sponsor
- Allergan
- Start
- Aug 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapsone in acne vulgaris, sponsored by Allergan. Started Aug 2010; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01231334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231334.